Brett Mason (Queensland, Liberal Party, Parliamentary Secretary to the Minister for Health and Ageing) Share this | Hansard source

Sorry, I misunderstood the question. The arrangements with respect to new drugs going onto what we call the F1 formulary will not be changed by this bill. The cost of those will remain the same—this bill does not affect them. When those F1 drugs come off patent—and generally they are copied by other companies—the community will save hundreds of millions of dollars, or possibly thousands of millions of dollars, by taking advantage of competition in the market for generics.